HALOZYME THERAPEUTICS, INC. - Common Stock (HALO)

CUSIP: 40637H109

Q4 2023 13F Holders as of 31 Dec 2023

Type / Class
Equity / Common Stock
Shares outstanding
123,650,000
Total 13F shares
124,680,353
Share change
+1,298,325
Total reported value
$4,614,991,205
Put/Call ratio
43%
Price per share
$36.96
Number of holders
409
Value change
+$45,612,024
Number of buys
195
Number of sells
183

Sponsored

Quarterly Holders Quick Answers

What is CUSIP 40637H109?
CUSIP 40637H109 identifies HALO - HALOZYME THERAPEUTICS, INC. - Common Stock in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Institutional Holders of HALOZYME THERAPEUTICS, INC. - Common Stock (HALO) as of Q4 2023

As of 31 Dec 2023, HALOZYME THERAPEUTICS, INC. - Common Stock (HALO) was held by 409 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 124,680,353 shares. The largest 10 holders included BlackRock Inc., VANGUARD GROUP INC, Artisan Partners Limited Partnership, STATE STREET CORP, SNYDER CAPITAL MANAGEMENT L P, ALLIANCEBERNSTEIN L.P., MACQUARIE GROUP LTD, JPMORGAN CHASE & CO, GEODE CAPITAL MANAGEMENT, LLC, and GW&K Investment Management, LLC. This page lists 409 institutional shareholders reporting positions in this security for the Q4 2023 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period

Compare Q4 2023 vs Q3 2023 Across Filers

Q3 2023 holders
389
Q4 2023 holders
409
Holder diff
20
Investor Q3 2023 Shares Q4 2023 Shares Share Diff Share Chg % Q3 2023 Value $ Q4 2023 Value $ Value Diff $ Value Chg %

Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).

Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.